{Reference Type}: Case Reports
{Title}: Cassia angustifolia and tacrolimus interaction in a liver transplant patient, a case report.
{Author}: Beltrá-Picó I;Díaz-González M;Nalda-Molina R;Ramon-Lopez A;Pascual-Bartolomé S;Miralles-Macià CF;Rodríguez-Soler M;Más-Serrano P;
{Journal}: Br J Clin Pharmacol
{Volume}: 90
{Issue}: 7
{Year}: 2024 Jul 24
{Factor}: 3.716
{DOI}: 10.1111/bcp.16079
{Abstract}: Cassia angustifolia is a species of plant from the Senna family that has traditionally been used as a laxative in different herbal products and commercial medicines. Even though there are few documented drug-plant interactions, the use of C. angustifolia with different drugs may have additive effects, such as with other laxatives or potassium-depleting diuretics. Its use also increases peristalsis which, may reduce drug absorption. The combination with digoxin has been associated with an increased risk of digoxin toxicity, probably due to an increase in plasma digoxin concentrations and hypokalaemia. We present a case with supratherapeutic trough concentration of tacrolimus, an immunosuppressive agent, and a herbal product in a liver transplant patient after concomitant intake of tacrolimus and a herbal product based on C. angustifolia, suggesting a possible drug-lant interaction through by P-glycoprotein. We observed an increase in the patient's blood concentration 2.8-fold and the area under the curve at steady state 2.1-fold. This interaction could be of clinical relevance, given the dose-dependent side effects of tacrolimus, such as nephrotoxicity, neurotoxicity, hypertension, hyperglycaemia, or electrolyte alterations.